NZ192421A - Benzoxadiazoles and benzothiadiazoles with 1,4-dihydroxy-pyridine moiety and pharmaceutical compositions - Google Patents

Benzoxadiazoles and benzothiadiazoles with 1,4-dihydroxy-pyridine moiety and pharmaceutical compositions

Info

Publication number
NZ192421A
NZ192421A NZ192421A NZ19242179A NZ192421A NZ 192421 A NZ192421 A NZ 192421A NZ 192421 A NZ192421 A NZ 192421A NZ 19242179 A NZ19242179 A NZ 19242179A NZ 192421 A NZ192421 A NZ 192421A
Authority
NZ
New Zealand
Prior art keywords
benzoxadiazoles
benzothiadiazoles
dihydroxy
pharmaceutical compositions
pyridine moiety
Prior art date
Application number
NZ192421A
Inventor
P Neumann
Original Assignee
Sandoz Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CH1289078A external-priority patent/CH643841A5/en
Priority claimed from CH1288878A external-priority patent/CH640852A5/en
Application filed by Sandoz Ltd filed Critical Sandoz Ltd
Publication of NZ192421A publication Critical patent/NZ192421A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
NZ192421A 1978-12-18 1979-12-17 Benzoxadiazoles and benzothiadiazoles with 1,4-dihydroxy-pyridine moiety and pharmaceutical compositions NZ192421A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
CH1289078A CH643841A5 (en) 1978-12-18 1978-12-18 Novel 1,4-dihydropyridine derivatives, their preparation and use
CH1288878A CH640852A5 (en) 1978-12-18 1978-12-18 1,4-Dihydropyridine derivatives, their preparation and use
CH347779 1979-04-11
CH347279 1979-04-11
CH562779 1979-06-15

Publications (1)

Publication Number Publication Date
NZ192421A true NZ192421A (en) 1982-09-07

Family

ID=27509137

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ192421A NZ192421A (en) 1978-12-18 1979-12-17 Benzoxadiazoles and benzothiadiazoles with 1,4-dihydroxy-pyridine moiety and pharmaceutical compositions

Country Status (7)

Country Link
CA (1) CA1131228A (en)
DE (1) DE2949464A1 (en)
GB (1) GB2041358B (en)
IL (1) IL58974A (en)
NZ (1) NZ192421A (en)
PT (1) PT70601A (en)
SE (1) SE7910151L (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3022030A1 (en) * 1980-06-12 1981-12-17 Bayer Ag, 5090 Leverkusen 4-THIAZOLE or 4-IMIDAZOLE-SUBSTITUTED, 1,4-DIHYDROPYRIDINE, METHOD FOR THE PRODUCTION THEREOF AND THE MEDICINAL PRODUCTS CONTAINING THEM
CH655658B (en) * 1980-09-18 1986-05-15
DE3269219D1 (en) * 1981-11-17 1986-03-27 Fisons Plc Dihydropyridines, methods for their production and their formulation and use as pharmaceuticals
ZA83959B (en) * 1982-03-10 1984-09-26 Sandoz Ltd 1,4-dihydropyridine derivatives,their preparation and pharmaceutical compositions containing them
EP0094159B1 (en) * 1982-05-10 1990-03-14 Takeda Chemical Industries, Ltd. Dihydropyridine derivatives, their production and use
FR2528431B1 (en) * 1982-06-15 1986-01-10 Sandoz Sa NOVEL 1,4-DIHYDROPYRIDINE DERIVATIVES, THEIR PREPARATION AND THEIR USE AS MEDICAMENTS
AU561213B2 (en) * 1983-06-02 1987-04-30 Teijin Limited 1, 4-dihydropyridine derivative
WO1985000169A1 (en) * 1983-06-21 1985-01-17 Sandoz Ag 1,4-dihydropyridine derivatives, production thereof and pharmaceutical preparations containing them
FR2554109A1 (en) * 1983-11-01 1985-05-03 Sandoz Sa NOVEL 1,4-DIHYDROPYRIDINE DERIVATIVES, THEIR PREPARATION AND USE IN THERAPEUTICS AS MEDICAMENTS
US4994476A (en) * 1984-10-31 1991-02-19 Bristol-Myers Company Dihydropyridin-3,5-dicarboxylates incorporating aryloxypropanolamine moieties
US5260321A (en) * 1984-11-12 1993-11-09 Sandoz Ltd. Use of 1,4-dihydropyridine derivatives and combinations thereof with calcitonins
IT1201454B (en) * 1985-08-19 1989-02-02 Boehringer Biochemia Srl 1,4-dihydropyridine-2-SUBSTITUTED

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1670824C3 (en) * 1967-03-20 1978-08-03 Bayer Ag, 5090 Leverkusen 1,4-Dihydropyridine-33-dicarboxylic acid alkyl ester
DE2117571C3 (en) * 1971-04-10 1979-10-11 Bayer Ag, 5090 Leverkusen Asymmetrical 1,4-dihydropyridine-33-dicarboxylic acid esters, process for their preparation and their use as pharmaceuticals
DE2218644C3 (en) * 1972-04-18 1982-08-19 Bayer Ag, 5090 Leverkusen Basic esters of 1,4-dihydropyridines, processes for their preparation and their use as pharmaceuticals
GB1455502A (en) * 1973-02-20 1976-11-10 Yamanouchi Pharma Co Ltd 1,4-dihydropyridine derivatives
FR2320750A1 (en) * 1975-08-12 1977-03-11 Hexachimie 1,4-DIHYDRO PYRIDINES AND THEIR THERAPEUTIC APPLICATION
DE2616991A1 (en) * 1976-04-17 1977-10-27 Bayer Ag Thio-substd. dihydro-pyridine derivs. - coronary vasodilators and antihypertensives prepd. e.g. by reacting dicarbonyl cpds. with amines and thio-substd. ketones
DE2740080A1 (en) * 1977-09-06 1979-03-15 Bayer Ag 2-Aminoalkyl-1,4-di:hydro-pyridine derivs. - with broad spectrum of effects on the heart and circulation, e.g. lowering blood pressure and spasmolytic effect

Also Published As

Publication number Publication date
GB2041358A (en) 1980-09-10
SE7910151L (en) 1980-06-19
IL58974A (en) 1983-03-31
GB2041358B (en) 1982-11-17
PT70601A (en) 1980-01-01
CA1131228A (en) 1982-09-07
IL58974A0 (en) 1980-03-31
DE2949464A1 (en) 1980-06-26

Similar Documents

Publication Publication Date Title
NZ190299A (en) 1,2,4-trizole -3,5- diamines and pharmaceutical compositions
IL58123A (en) 4,5-diaryl-2-nitroimidazoles,their preparation and pharmaceutical compositions containing them
IL57020A (en) Carbazolyl-(4)-oxypropanolamine derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
PH14086A (en) Cyclosporin derivatives and pharmaceutical compositions thereof
NZ189378A (en) 4-amino-5-alkylsulphonyl-ortho-anisamdes and pharmaceutical compositions
NZ190745A (en) Mercapto-substituted -2,3,4,5-tetrahydro-1h-3-benzazepines and pharmaceutical compositions
NZ192422A (en) Benzoxadiazoles and benzothiadiazoles with 1,4-dihydropyridine moiety pharmaceutical compositions
PH16519A (en) 1,2,3,4-tetrahydro-2-amino-5-oxy-naphthalene derivatives and their pharmaceutical compositions
NZ190784A (en) Benzofuranyl-piperidines and pharmaceutical compositions
NZ185965A (en) 5'-deoxy-5-fluor ocytidine, 5'-deoxy-5-fluoro-uridine and pharmaceutical compositions
NZ192421A (en) Benzoxadiazoles and benzothiadiazoles with 1,4-dihydroxy-pyridine moiety and pharmaceutical compositions
IL58478A0 (en) Pharmaceutical composition containing 3,4-dihydro-3-oxo-2-quinoxalines
DE2962423D1 (en) Solid stable pharmaceutical composition on the basis of a 1,3-diester of 17-alpha-ethynyl-7-alpha-methyl-1,3,5(10)-estratriene-1,3,17-beta-triol
IL56808A0 (en) 1-oxo-1h-pyrimido(6,1)benztheazole derivatives,process forthe preparation thereof and pharmaceutical compositions containing the same
NZ189881A (en) 4,5-diaryl-2-(substituted-thio)-pyrroles and pharmaceutical compositions
NZ189930A (en) 1,1-diphenylethene derivatives and fugicidal compositions
NZ185539A (en) Cis-4a-aryl-2-substituted-2,3,4,4a,5,6,7,7a-octa hydro-1h-2-pyrindines and pharmaceutical compositions
NZ187825A (en) 1,2,4-oxadiazole derivatives and pharmaceutical compositions
NZ190412A (en) 2,4-dichloro-a-(n-imidazolyl-methyl)-dibenzyl ethers and pharmaceutical compositions
NZ189769A (en) Benzylidene derivatives and pharmaceutical compositions
NZ184185A (en) 3,5,5-trimethylhexanoyl-ferrocene and pharmaceutical compositions
NZ189279A (en) Arylaminoimidazolines and pharmaceutical compositions
NZ189703A (en) N'-glucofuranosid-6-yl-n3-nitroso-ureas and pharmaceutical compositions
NZ190278A (en) 6,7-benzomorphan derivatives and pharmaceutical compositions
NZ190293A (en) Benzimidoyl-piperazines and pharmaceutical compositions